EFFECTIVE DOSE RANGE OF ENALAPRIL IN MILD TO MODERATE ESSENTIAL-HYPERTENSION

被引:19
作者
BERGSTRAND, R
HERLITZ, H
JOHANSSON, S
BERGLUND, G
VEDIN, A
WILHELMSSON, C
GOMEZ, HJ
CIRILLO, VJ
BOLOGNESE, JA
机构
[1] SAHLGRENSKA HOSP, DEPT MED, Gothenburg, SWEDEN
[2] MERCK SHARP & DOHME RES LABS, DEPT CARDIOVASC CLIN RES, RAHWAY, NJ 07065 USA
[3] MERCK SHARP & DOHME RES LABS, DEPT CLIN BIOSTAT, RAHWAY, NJ 07065 USA
关键词
D O I
10.1111/j.1365-2125.1985.tb02687.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:605 / 611
页数:7
相关论文
共 24 条
[11]   ANALYSIS OF CATEGORICAL DATA BY LINEAR MODELS [J].
GRIZZLE, JE ;
STARMER, CF ;
KOCH, GG .
BIOMETRICS, 1969, 25 (03) :489-&
[12]  
Hodsman G P, 1983, J Hypertens Suppl, V1, P109
[13]   REFLEX-HEMODYNAMIC ADJUSTMENTS AND BAROREFLEX SENSITIVITY DURING CONVERTING ENZYME-INHIBITION WITH MK-421 IN NORMAL HUMANS [J].
IBSEN, H ;
EGAN, B ;
OSTERZIEL, K ;
VANDER, A ;
JULIUS, S .
HYPERTENSION, 1983, 5 (02) :I184-I191
[14]   PHARMACODYNAMICS OF CONVERTING ENZYME-INHIBITION - THE CARDIOVASCULAR, ENDOCRINE AND AUTONOMIC EFFECTS OF MK421 (ENALAPRIL) AND MK521 [J].
MILLAR, JA ;
DERKX, FHM ;
MCLEAN, K ;
REID, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :347-355
[15]  
PATCHETT AA, 1980, NATURE, V288, P280, DOI 10.1038/288280a0
[16]  
Rabinad Estrada E, 1982, Br J Clin Pharmacol, V14 Suppl 2, p103S
[17]  
Reid J L, 1983, J Hypertens Suppl, V1, P129
[18]   LONG-TERM CAPTOPRIL TREATMENT IN MODERATE TO SEVERE HYPERTENSION [J].
SANTUCCI, A ;
AGUGLIA, F ;
DEMATTIA, G ;
FICARA, C ;
BALSANO, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 :S77-S79
[19]   INCREASED RENAL PLASMA-FLOW IN LONG-TERM ENALAPRIL TREATMENT OF HYPERTENSION [J].
SIMON, G ;
MORIOKA, S ;
SNYDER, DK ;
COHN, JN .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (04) :459-465
[20]   LONG-TERM EFFICACY OF ANGIOTENSIN-CONVERTING-ENZYME INHIBITION WITH CAPTOPRIL IN MILD-TO-MODERATE ESSENTIAL-HYPERTENSION [J].
STUMPE, KO ;
OVERLACK, A ;
KOLLOCH, R ;
SCHREYER, S .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 :S121-S126